Company profile: Angiodroid
1.1 - Company Overview
Company description
- Provider of automatic carbon dioxide angiography solutions for hemodynamics, vascular surgery, and interventional radiology, including Angiodroid The CO2 Injector for peripheral diagnostic and interventional procedures, the Angiodroid Easy Kit disposable accessories, ANGIOPULSE counterpulsation weaning console, and the ACDA Academy offering training, articles, conferences, and live case streaming.
Products and services
- Angiodroid The CO2 Injector: A digital, automatic system that injects carbon dioxide for angiography, acting as a contrast medium in peripheral diagnostic and interventional procedures
- ANGIOPULSE: A console-based device architected for counterpulsation weaning, assisting patients’ recovery with accurate settings and operation that requires no signal synchronization during therapy
- Angiodroid Easy Kit: A sterile disposable kit with a single-use adaptor and two-way manifold enabling multiple-device connections to the angiographic catheter for Angiodroid The CO2 Injector
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Angiodroid
Excision Medical
HQ: United States
Website
- Description: Provider of tools for TAVR procedures focused on safe, reliable leaflet modification and excision, device steering, and temporary hemodynamic support. Offerings include the Leaflet Excision System to target and excise aortic valve leaflets and mitigate risks during redo TAVR, Stýri steering catheters, Viking RF Excision Catheter, and HemoShield temporary valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Excision Medical company profile →
InteloMed
HQ: United States
Website
- Description: Provider of non-invasive, real-time cardiopulmonary monitoring solutions. Offers InteloMed TeleHealth Technology that uses facial scans during virtual consultations to deliver pulse and respiration metrics to clinicians. Engages in a NASA-supported project to develop non-contact monitoring for personnel and conducts an IRB-reviewed clinical study to validate its algorithms against traditional methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InteloMed company profile →
CardioDynamics
HQ: United States
Website
- Description: Provider of noninvasive impedance cardiography diagnostic and monitoring devices and proprietary ICG sensors, including BioZ Dx, BioZ ICG Monitor, BioZ ICG Module, BioZtect sensors, Niccomo and Cardioscreen monitor, and Rheoscreen measurement devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioDynamics company profile →
InCarda Therapeutics
HQ: United States
Website
- Description: Provider of inhalation-route therapies for cardiovascular conditions, developing an orally inhaled flecainide to treat acute episodes of paroxysmal atrial fibrillation (PAF) using approved drugs in a new dosing method, and advancing additional cardiology programs addressing unmet needs toward clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InCarda Therapeutics company profile →
Aptus Endosystems
HQ: United States
Website
- Description: Provider of advanced endovascular technologies for treating aortic aneurysm disease, focused on EVAR for abdominal aortic aneurysms. Offerings include a unique endograft and an endovascular stapling system that provides a durable alternative to open surgical repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Endosystems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Angiodroid
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Angiodroid
2.2 - Growth funds investing in similar companies to Angiodroid
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Angiodroid
4.2 - Public trading comparable groups for Angiodroid
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →